Clinical trial

Ipilimumab-induced Lung Toxicity: Observational Study

NCT02755233

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-01-01

PhaseN/A

Study timeline

Study start (unknown)2014-01-01Date precision: month

Registry last updated2016-04-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Melanomaverified · MONDO: metastatic melanoma

Interventions

Pulmonary FunctionOTHER

Sponsors & collaborators

University of Zurichlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02755233 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.